Barrett Elizabeth A. 4
4 · UroGen Pharma Ltd. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Barrett Elizabeth A.
Chief Executive Officer
Transactions
- Award
Restricted Stock Units
2024-01-31+87,615→ 87,615 total→ Ordinary Shares (87,615 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027.